Novel targeted therapies in inflammatory
โ
Massimo Cristofanilli
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 84 KB
๐ 2 views
## Abstract Inflammatory breast cancer (IBC) accounts for 1% to 5% of all breast cancer cases. Its aggressive biology is characterized by rapid disease progression and poor prognosis. To improve and standardize therapy for IBC, development of novel therapeutics to molecular targets of IBC is key. T